After trying to back out, Hill-rom will proceed with $375M deal to acquire Seattle’s Bardy Diagnostics
Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy photo) Medical technology company Hill-rom has dismissed its attorneys after initially backing off a $ 375 million acquisition of Seattle startup Bardy Diagnostics. The deal to acquire Bardy will now continue, Hill-rom CEO John Groetelaars said in a call to investors on July 30th. Founded in 2013, … Read more